Published in J R Coll Gen Pract on May 01, 1971
A randomized controlled trial of geriatric screening and surveillance in general practice. J R Coll Gen Pract (1979) 7.62
The clinical features of chronic vitamin deficiency. A therapeutic trial in geriatric hospital patients. Gerontol Clin (Basel) (1968) 2.09
Leucocyte-vitamin-C content and clinical signs in the elderly. Lancet (1966) 1.92
Vitamin C concentration of plasma and leukocytes as related to smoking habit, age, and sex of humans. Am J Clin Nutr (1968) 1.82
Vitamin C supplementation in the elderly: a 17-month trial in an old persons' home. Br Med J (1969) 1.23
Smoking and vitamin C levels in humans. Am J Clin Nutr (1968) 1.18
Vitamins in health and disease. Practitioner (1968) 0.94
Crystal structure of the extracellular segment of integrin alpha Vbeta3. Science (2001) 8.12
Long-term outcome of treating rheumatoid arthritis: results after 20 years. Lancet (1987) 2.81
Cancer morbidity in rheumatoid arthritis. Ann Rheum Dis (1984) 2.67
Sensorimotor changes and functional performance in patients with knee osteoarthritis. Ann Rheum Dis (1997) 2.39
The way forward for hydrotherapy. Br J Rheumatol (1993) 2.15
Cause of death in rheumatoid arthritis. Br J Rheumatol (1984) 2.12
The clinical features of chronic vitamin deficiency. A therapeutic trial in geriatric hospital patients. Gerontol Clin (Basel) (1968) 2.09
Can patients benefit from reading copies of their doctors' letters about them? Br Med J (Clin Res Ed) (1986) 2.04
The three-dimensional crystal structure of cholera toxin. J Mol Biol (1995) 2.03
Nutritional Macrocytic Anaemia and the Animal Protein of Diet. Br Med J (1945) 2.03
Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well. J Rheumatol (1998) 2.00
Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. Rheumatology (Oxford) (2001) 1.96
Progression of radiological changes in rheumatoid arthritis. Ann Rheum Dis (1984) 1.86
Patients with stable long-standing rheumatoid arthritis continue to deteriorate despite intensified treatment with traditional disease modifying anti-rheumatic drugs--results of the British Rheumatoid Outcome Study Group randomized controlled clinical trial. Rheumatology (Oxford) (2005) 1.84
Lymphoedema of the limbs as an extra-articular feature of rheumatoid arthritis. Ann Rheum Dis (1990) 1.79
Crystal structure of cobra-venom phospholipase A2 in a complex with a transition-state analogue. Science (1990) 1.77
The long-term effects of treating rheumatoid arthritis. J R Coll Physicians Lond (1983) 1.70
Non-steroidal anti-inflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trials. Ann Rheum Dis (2007) 1.68
Lymphoproliferative malignancy in rheumatoid arthritis: a study of 20 cases. Ann Rheum Dis (1984) 1.66
Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications. Ann Rheum Dis (1992) 1.65
Frequency of occurrence, mode of development, and significance or rice bodies in rheumatoid joints. Ann Rheum Dis (1982) 1.62
Joint counts in routine practice. Rheumatology (Oxford) (2003) 1.62
Phosphoinositides in mitogenesis: neomycin inhibits thrombin-stimulated phosphoinositide turnover and initiation of cell proliferation. Cell (1985) 1.62
Fatigue in rheumatoid arthritis reflects pain, not disease activity. Rheumatology (Oxford) (2006) 1.58
What happens to patients with rheumatoid arthritis? The long-term outcome of treatment. Clin Rheumatol (1988) 1.58
Deaths from domestic falls and fractures. Br J Prev Soc Med (1972) 1.54
The consequences of rheumatoid arthritis: quality of life measures in the individual patient. Clin Exp Rheumatol (2005) 1.51
Quality of life, morbidity, and mortality after low trauma hip fracture in men. Ann Rheum Dis (2005) 1.48
Rest or exercise in inflammatory arthritis? Br J Hosp Med (1992) 1.47
Current concepts and new developments in the treatment of psoriatic arthritis. Rheumatology (Oxford) (2003) 1.47
Injections and physiotherapy for the painful stiff shoulder. Ann Rheum Dis (1989) 1.45
Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial. Ann Rheum Dis (2010) 1.45
The distribution of fibronectin in the pannus in rheumatoid arthritis. Br J Exp Pathol (1981) 1.41
Septic arthritis complicating hip osteoarthritis. Ann Rheum Dis (1991) 1.40
Dental Caries, Vitamin D, and Mineral Deficiencies. Br Med J (1939) 1.38
Body temperatures in the elderly. Lancet (1970) 1.37
Care giver perception of children's obesity-related health risk: a study of African American families. Obes Res (2000) 1.37
Improvements in quadriceps sensorimotor function and disability of patients with knee osteoarthritis following a clinically practicable exercise regime. Br J Rheumatol (1998) 1.35
Significance of fibronectin in rheumatoid arthritis and osteoarthrosis. Ann Rheum Dis (1981) 1.35
Significance of laminar antikeratin antibodies to rat oesophagus in rheumatoid arthritis. Ann Rheum Dis (1981) 1.31
The spongistatins, potently cytotoxic inhibitors of tubulin polymerization, bind in a distinct region of the vinca domain. Biochemistry (1995) 1.29
Construction and validation of a quality of life questionnaire for neuromuscular disease (INQoL). Neurology (2007) 1.28
The 2.4 A crystal structure of cholera toxin B subunit pentamer: choleragenoid. J Mol Biol (1995) 1.26
Outbreak of Jaundice with Nervous Signs. Br Med J (1945) 1.25
Factorial randomised controlled trial of glucocorticoids and combination disease modifying drugs in early rheumatoid arthritis. Ann Rheum Dis (2007) 1.23
Nutritional and environmental studies on an ocean-going oil tanker. 2. Heat acclimatization and nutrient balances. Br J Ind Med (1971) 1.21
Long term progression of joint damage in rheumatoid arthritis. Ann Rheum Dis (1986) 1.20
The management of knee pain in primary care: factors associated with consulting the GP and referrals to secondary care. Rheumatology (Oxford) (2006) 1.18
Anti-rheumatic drugs and joint damage in rheumatoid arthritis. Q J Med (1985) 1.17
Clinical value of ELISA assays for IgM and IgG rheumatoid factors. J Clin Pathol (1987) 1.15
Survival of gram-negative bacteria on plastic compounded with hexachlorophene. Appl Microbiol (1970) 1.15
A systematic review and meta-analysis of efficacy and toxicity of disease modifying anti-rheumatic drugs and biological agents for psoriatic arthritis. Ann Rheum Dis (2007) 1.13
Studies on reticulin. I: Serological and immunohistological investigations of the occurrence of collagen type III, fibronectin and the non-collagenous glycoprotein of Pras and Glynn in reticulin. Br J Exp Pathol (1982) 1.13
Hand bone densitometry in rheumatoid arthritis, a five year longitudinal study: an outcome measure and a prognostic marker. Ann Rheum Dis (2003) 1.12
Prediction of progressive joint damage in patients with rheumatoid arthritis receiving gold or D-penicillamine therapy. Ann Rheum Dis (1986) 1.11
A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal. Rheumatology (Oxford) (2005) 1.10
Control of rheumatoid arthritis by oral tolerance. Arthritis Rheum (2001) 1.09
Patient-reported outcomes better discriminate active treatment from placebo in randomized controlled trials in rheumatoid arthritis. Rheumatology (Oxford) (2004) 1.09
Nutritional and environmental studies on an ocean-going oil tanker. 1. Thermal environment. Br J Ind Med (1971) 1.08
WHO Collaborating Centre consensus meeting on anti-cytokine therapy in rheumatoid arthritis. Rheumatology (Oxford) (2001) 1.06
Bone mineral density, hip axis length and risk of hip fracture in men: results from the Cornwall Hip Fracture Study. Osteoporos Int (2000) 1.05
Thrombocytosis of active rheumatoid disease. Ann Rheum Dis (1983) 1.05
Fibronectin and immune complexes in rheumatic diseases. Ann Rheum Dis (1987) 1.03
Relationship of gold and penicillamine therapy to diffuse interstitial lung disease. Ann Rheum Dis (1981) 1.03
Cardiac pacemakers as an anaesthetic problem. Anaesthesia (1970) 1.03
Methods of X-ray assessment in rheumatoid arthritis: a re-evaluation. Br J Rheumatol (1985) 1.03
Variations in responses to non-steroidal anti-inflammatory drugs. Br J Clin Pharmacol (1982) 1.01
The preparation of plasma fibronectin antigen and antiserum. J Immunol Methods (1981) 1.01
Patients' views on the quality of health care for rheumatoid arthritis. Rheumatology (Oxford) (2006) 1.01
The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis. Health Technol Assess (2005) 1.00
2.0 A X-ray structure of the ternary complex of 7,8-dihydro-6-hydroxymethylpterinpyrophosphokinase from Escherichia coli with ATP and a substrate analogue. FEBS Lett (1999) 1.00
Cartilage degradation by polymorphonuclear leucocytes: in vitro assessment of the pathogenic mechanisms. Ann Rheum Dis (1993) 1.00
Nonsteroidal antiinflammatory drugs and uncoupling of mitochondrial oxidative phosphorylation. Arthritis Rheum (1996) 1.00
The use of 'alternative treatments' by patients with rheumatoid arthritis. Rheumatol Int (1983) 0.98
Musculoskeletal disorders in patients with hyperlipidaemia. Ann Rheum Dis (1983) 0.98
Coal smoke and mortality of the elderly. Nature (1974) 0.98
Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study Group. J Rheumatol (2001) 0.98
Early referral and outcome in rheumatoid arthritis. Scand J Rheumatol (1998) 0.97
What proteins are present in polyethylene glycol precipitates from rheumatic sera? Ann Rheum Dis (1989) 0.97
Joint space in radiologically normal knees. Br J Rheumatol (1991) 0.97
Interventions for foot disease in rheumatoid arthritis: a systematic review. Arthritis Rheum (2005) 0.96
Septic arthritis and thigh abscess after dilatation and curettage. Clin Rheumatol (1984) 0.96
A pharmacist's audit of antirheumatic drugs. Rheumatol Rehabil (1982) 0.96
Rheumatoid factor isotypes, disease activity and the outcome of rheumatoid arthritis: comparative effects of different antigens. Scand J Rheumatol (1998) 0.94
Sulphasalazine desensitisation in rheumatoid arthritis. Br Med J (Clin Res Ed) (1982) 0.94
Clinical significance of IgA rheumatoid factor subclasses in rheumatoid arthritis. J Rheumatol (1997) 0.94
Aphasia and hemiparesis following stellate ganglion block. Anesth Analg (1983) 0.93
The prevention and healing of acute non-steroidal anti-inflammatory drug-associated gastroduodenal mucosal damage by misoprostol. Br J Rheumatol (1993) 0.93
Deaths from falls and fractures. Comparison of mortality in Scotland and the United States with that in England and Wales. Br J Prev Soc Med (1973) 0.93
Fragmented fibronectin and other synovial fluid proteins in chronic arthritis: their relation to immune complexes. Clin Chim Acta (1989) 0.93
Measuring health status and outcomes in rheumatoid arthritis within routine clinical practice. Br J Rheumatol (1994) 0.93
Sex differences in inflammation induced cartilage damage in rodents. The influence of sex steroids. J Rheumatol (1994) 0.93
The long-term use of D-penicillamine for treating rheumatoid arthritis: is continuous therapy necessary? Br J Rheumatol (1993) 0.93
Magnetic pulse treatment for knee osteoarthritis: a randomised, double-blind, placebo-controlled study. Curr Med Res Opin (2001) 0.93
A model of persistent antigen-induced chronic inflammation in the rat air pouch. Br J Exp Pathol (1984) 0.93
A comparative radiological study of the pubic symphysis in rheumatic disorders. Ann Rheum Dis (1979) 0.93
Rheumatoid arthritis and senile dementia of the Alzheimer's type. Br J Rheumatol (1989) 0.92
Caffeine in plasma and saliva by a radioimmunoassay procedure. J Pharmacol Exp Ther (1976) 0.92